{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:54:11Z","timestamp":1791568451897,"version":"4.3.4"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.exphem.2026.105487","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T15:15:44Z","timestamp":1785338144000},"page":"105487","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Clinical Response to Thalidomide in Non\u2013Transfusion-Dependent Thalassemia Complicated by Autoimmune Hemolytic Anemia: A Case Report and Literature Review"],"prefix":"10.1016","volume":"162","author":[{"given":"Nada","family":"Sbeiti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4261-3828","authenticated-orcid":false,"given":"Mohammad Hassan","family":"Hodroj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8515-2238","authenticated-orcid":false,"given":"Ali T.","family":"Taher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2026.105487_bib0001","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1182\/bloodadvances.2020002725","article-title":"The use of luspatercept for thalassemia in adults","volume":"5","author":"Cappellini","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.exphem.2026.105487_bib0002","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3390\/ph15060753","article-title":"Pharmacological induction of fetal hemoglobin in \u03b2-thalassemia and sickle cell disease: an updated perspective","volume":"15","author":"Bou-Fakhredin","year":"2022","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.exphem.2026.105487_bib0003","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1080\/03630269.2024.2386076","article-title":"Thalidomide and hydroxyurea in transfusion-dependent thalassemia: efficacy, safety profile and impact on quality of life","volume":"48","author":"Bhattacharjee","year":"2024","journal-title":"Hemoglobin"},{"key":"10.1016\/j.exphem.2026.105487_bib0004","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.clinthera.2025.01.008","article-title":"Effects of thalidomide on metabolism and lifespan of red blood cell in patients with \u03b2-thalassemia major: a post hoc analysis of a randomized controlled trial","volume":"47","author":"Yang","year":"2025","journal-title":"Clin Ther"},{"key":"10.1016\/j.exphem.2026.105487_bib0005","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/ajh.27557","article-title":"Evaluating the role of red blood cell lifespan in transfusion-dependent \u03b2-thalassemia and impact of thalidomide treatment","volume":"100","author":"Yang","year":"2025","journal-title":"Am J Hematol"},{"key":"10.1016\/j.exphem.2026.105487_bib0006","doi-asserted-by":"crossref","DOI":"10.4084\/MJHID.2026.033","article-title":"Efficacy and safety of thalidomide in patients with transfusion-dependent \u03b2-thalassemia: a systematic review, meta-analysis and GRADE evaluation","volume":"18","author":"Li","year":"2026","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.exphem.2026.105487_bib0007","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-026-46504-y","article-title":"Efficacy and safety of thalidomide in \u03b2-thalassaemia: a systematic review and meta-analysis","volume":"16","author":"Yasara","year":"2026","journal-title":"Sci Rep"},{"key":"10.1016\/j.exphem.2026.105487_bib0008","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1615\/CritRevImmunol.v22.i5-6.40","article-title":"Immunological effects of thalidomide and its chemical and functional analogs","volume":"22","author":"Dredge","year":"2002","journal-title":"Crit Rev Immunol"},{"key":"10.1016\/j.exphem.2026.105487_bib0009","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bcmd.2016.01.003","article-title":"The long-term and extensive efficacy of low-dose thalidomide in a case of an untransfusable patient with non-transfusion-dependent thalassemia","volume":"57","author":"Ricchi","year":"2016","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.exphem.2026.105487_bib0010","article-title":"Efficacy of thalidomide treatment in children with transfusion-dependent \u03b2-thalassemia: a retrospective clinical study","volume":"12","author":"Li","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.exphem.2026.105487_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcmd.2025.102936","article-title":"Thalidomide confers therapeutic benefit in beta thalassemia patients by enhancing hemoglobin and hematopoietic gene expression: a non-randomized clinical trial","volume":"113-114","author":"Rahman","year":"2025","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.exphem.2026.105487_bib0012","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s12288-019-01231-5","article-title":"Promising response to thalidomide in symptomatic \u03b2-thalassemia","volume":"36","author":"Yassin","year":"2020","journal-title":"Indian J Hematol Blood Transfus"},{"key":"10.1016\/j.exphem.2026.105487_bib0013","doi-asserted-by":"crossref","DOI":"10.4084\/MJHID.2024.001","article-title":"Effects of thalidomide on erythropoiesis and iron homeostasis in transfusion-dependent \u03b2-thalassemia","volume":"16","author":"Yang","year":"2024","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.exphem.2026.105487_bib0014","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41392-021-00811-0","article-title":"Safety and efficacy of thalidomide in patients with transfusion-dependent \u03b2-thalassemia: a randomized clinical trial","volume":"6","author":"Chen","year":"2021","journal-title":"Signal Transduct Target Ther"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X26001207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X26001207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:23:54Z","timestamp":1791566634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X26001207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":14,"alternative-id":["S0301472X26001207"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2026.105487","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Response to Thalidomide in Non\u2013Transfusion-Dependent Thalassemia Complicated by Autoimmune Hemolytic Anemia: A Case Report and Literature Review","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2026.105487","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Society for Experimental Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105487"}}